Description of Research Expertise:
Peter Reese, MD, MSCE is a transplant nephrologist and epidemiologist. He cares for patients at the Hospital of the University of Pennsylvania and the Philadelphia Veterans Affairs Medical Center.
His research focuses on: a) developing effective strategies to increase access to kidney transplantation, b) improving the process of selecting and caring for live kidney donors, c) determining outcomes of health policies on vulnerable populations with renal disease, including the elderly, and d) testing strategies to improve important health behaviors such as medication adherence. He directs Penn’s Center for Quality, Analytics and Research in Transplantation (PQART). He also chairs the Ethics Committee for the United Network for Organ Sharing (UNOS), which oversees organ allocation and transplant regulation in the United States. In recognition of his contributions to transplant research, he received a Presidential Early Career Award for Scientists and Engineers (PECASE) in July 2012. The PECASE "recognizes and supports scientists and engineers who show exceptional promise for leadership at the frontiers of scientific knowledge."
In the transplant field, Dr. Reese has written specifically about the ethical implications of accepting live kidney donors with risk factors for kidney disease, live donor outcomes, the effects of organ allocation policy on vulnerable subgroups including children and the elderly, and better strategies to promote the careful use of higher-risk organs (e.g., “medically complex donors”).
Dr. Reese’s mission encompasses energetic support of talented and motivated young researchers at all stages of training. This Lab’s success reflects their creativity and efforts.
Dr. Reese's research support has included funds generously provided by:
· The National Institutes of Health
· A T. Franklin Williams Award in geriatric research (co-sponsored by the Association of Specialty Professors and the American Society of Nephrology) to examine the effects of emerging organ allocation proposals on older kidney transplant candidates
· The American Society of Transplantation to study outcomes among older live kidney donors
· A Greenwall Faculty Scholars Grant to examine the ethical implications of novel methods to increase organ donor registration
· CVS-Caremark, Merck, and Humana to test innovative strategies for improving medication adherence
Additional information about Dr. Reese’s current research can be found here: http://www.med.upenn.edu/reeselab/
Description of Content-based Expertise
Renal Epidemiology, Organ Transplantation, Ethics”
Choudhry RA, Reese PP, Goldberg DS, Bloom RD, Sawinski DL: A Paired Kidney Analysis of Multiorgan Transplantation: Implications for Allograft Survival Transplantation 10 (2): 268-376,2017.
Puthumana J, Hall IE, Reese PP, Schröppel B, Weng FL, Thiessen-Philbrook H, Doshi MD, Rao V, Lee CG, Elias JA, Cantley LG: YKL-40 Associates with Renal Recovery in Deceased Donor Kidney Transplantation Journal of the American Society of Nephrology 28 (2): 661-670,2017.
Sautenet B, Tong A, Manera KE, Chapman JR, Warrens AN, Rosenbloom D, Wong G, Gill J, Budde K, Rostaing L, Marson L, Josephson MA, Reese PP, Pruett TL, Hanson CS, O'Donoghue D, Tam-Tham H, Halimi JM, Shen JI, Kanellis J, Scandling JD, Howard K, Howell M, Cross N, Evangelidis N, Masson P, Oberbauer R, Fung S, Jesudason S, Knight S, Mandayam S, McDonald SP, Chadban S, Rajan T: Developing Consensus-Based Priority Outcome Domains for Trials in Kidney Transplantation: A Multinational Delphi Survey With Patients, Caregivers, and Health Professionals Transplantation 101 (8): 1875-1886,2017.
Hall IE, Reese PP, Doshi MD, Weng FL, Schroppel B, Asch WS, Ficek J, Thiessen-Philbrook H: Delayed graft function phenotypes and 12-month kidney transplant outcomes Transplantation 101 (8): 1913-1923,2017.
Tong A, Gill J, Budde K, Marson L, Reese PP, Rosenbloom D, Rostaing L, Wong G, Josephson MA, Pruett TL, Warrens AN, Craig JC, Sautenet B, Evangelidis N, Ralph AF, Hanson CS, Shen JI, Howard K, Meyer K, Perrone RD, Weiner DE, Fung S, Ma MKM, Rose C, Ryan J, Chen LX, Howell M, Larkins N, Kim S, Thangaraju S, Ju A: Toward Establishing Core Outcome Domains For Trials in Kidney Transplantation: Report of the Standardized Outcomes in Nephrology-Kidney Transplantation Consensus Workshops Transplantation 101 (8): 1887-1896,2017.
Laskin BL, Jiao J, Baluarte HJ, Amaral S, Furth SL, Akimova T, Hancock WW, Levine MH, Reese PP: The Effects of Tacrolimus on T-Cell Proliferation Are Short-Lived: A Pilot Analysis of Immune Function Testing Transplant Direct 3 (8): e199,2017.
Koyawala N, Silber JH2, Rosenbaum PR, Wang W, Hill AS, Reiter JG, Niknam BA, Even-Shoshan O, Bloom RD, Sawinski D, Nazarian S, Trofe-Clark J, Lim MA, Schold JD: Comparing Outcomes between Antibody Induction Therapies in Kidney Transplantation Journal of the American Society of Nephrology 28 (7): 2188-2200,2017.
Goldberg DS, Abt PL, Blumberg EA, Van Deerlin VM, Levine M, Reddy KR, Bloom RD, Nazarian SM, Sawinski D, Porrett P, Naji A, Hasz R, Suplee L, Trofe-Clark J, Sicilia A, McCauley M, Farooqi M, Gentile C, Smith J: Trial of Transplantation of HCV-Infected Kidneys into Uninfected Recipients New England Journal of Medicine 15 (376): 2394-2395,2017.
Doshi M, Reese PP, Hall IE,Schröppel B, Ficek J, Formica RN, Weng FL, Hazs RD, Thiessen Philbrook H: Utility of applying quality assessment tools for kidneys with KDPI ≥80 Transplantation 101 (6): 1125-1133,2017.
Cohen JB, Eddinger KC, Locke JE, Forde KA, Reese PP: Survival Benefit of Transplantation with a Deceased Diabetic Donor Kidney Compared with Remaining on the Waitlist Clinical Journal of the American Society of Nephrology 12 (6): 974-982,2017.